6/23/2014 6:07:04 AM
(Reuters) - Swiss drugmaker Roche said it will partner with Inception Sciences Inc. and Versant Ventures on a new company to develop therapies for patients with multiple sclerosis.
The move is part of the Basel-based firm's efforts to diversify beyond its expertise in cancer by developing treatments for Alzheimer's disease, schizophrenia as well as multiple sclerosis, among other neurodegenerative disorders.
Help employers find you! Check out all the jobs and post your resume.
comments powered by